Multilevel therapeutic targeting by topoisomerase inhibitors.
about
Multimodality imaging of tumor response to doxilImpact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.Topotecan-based combination chemotherapy in patients with transformed chronic myelogenous leukemia and advanced myelodysplastic syndromePDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model.
P2860
Multilevel therapeutic targeting by topoisomerase inhibitors.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Multilevel therapeutic targeting by topoisomerase inhibitors.
@en
type
label
Multilevel therapeutic targeting by topoisomerase inhibitors.
@en
prefLabel
Multilevel therapeutic targeting by topoisomerase inhibitors.
@en
P2860
P1476
Multilevel therapeutic targeting by topoisomerase inhibitors.
@en
P2093
P2860
P304
P577
1994-09-01T00:00:00Z